Becton, Dickinson and Company (NYSE:BDX) has steady demand for its medical devices, together with a long history of paying ...

Shares of Becton, Dickinson (NYSE:BDX) traded sharply lower on Thursday after the medical equipment maker lowered its full-year earnings and growth outlook with its Q2 fiscal 2025 financials, leading ...

Becton Dickinson (BDX) just put fresh clinical data in front of investors. Nine-month results from the AGILITY trial for its ...

Becton, Dickinson and Company is currently listed on NYSE under BDX. One share of BDX stock can currently be purchased for approximately $187.37. Is Becton, Dickinson and Company (BDX) overvalued or ...

A company-specific look at Becton Dickinson, the current market theme surrounding BDX, its operating relevance and the evidence needed to assess what follows.

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500) closed up 0.59%, the Dow (DJI) jumped 0.83%, and the Nasdaq Composite (COMP:IND) ...

Becton Dickinson stock was trading at USD 180.19 on the NYSE on September 24, 2026, at 2:56 p.m. ET, down 1.28 percent from USD 182.52. The price stood below the 52-week high of USD 193.07 as the ...

Market Cap as of today is 49.779 B. Compare the current Market Cap against historical performance and benchmark the BDX Market Cap against competitors.

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

American medical manufacturer Becton Dickinson said Oct. 6 it will invest $19 billion in the United States over several years ...

Becton Dickinson said a device aimed at treating iliac artery disease met the primary composite endpoint in a recent trial. The medical-device maker said Wednesday that treatment with its Revello ...